Cell Therapeutics files sBLA for lymphoma drug
If approved, Zevalin would be the only radioimmunotherapy in the US with approval for use as first-line consolidation therapy. The company has requested priority review, which if granted,
The US Food and Drug Administration (FDA) has declined to approve Unicycive Therapeutics’ resubmitted new drug application (NDA) for oxylanthanum carbonate (OLC) to treat hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis.
Firebird is a comprehensive system with a modular screw designed to provide surgeons with intra-operative flexibility during various thoracolumbar spine procedures, including the treatment of degenerative disc disease